These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16962355)

  • 21. [Regional lymph nodes at a distance].
    Kroon BB; Hoefnagel CA; Valdés Olmos RA; Nieweg OE
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):1997-2000. PubMed ID: 18825884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
    Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
    J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A; Largillier R; Ferrero JM; Lallement M; Raoust I; Ettore F; Peyrottes I; Chamorey E; Balu-Maestro C; Chapellier C
    Oncology; 2006; 71(5-6):361-8. PubMed ID: 17785993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
    Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
    Altinyollar H; Berberoğlu U; Gülben K; Irkin F
    J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
    Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
    Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The feasibility of sentinel node biopsy in the previously treated breast.
    Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
    Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
    Overgaard M; Nielsen HM; Overgaard J
    Radiother Oncol; 2007 Mar; 82(3):247-53. PubMed ID: 17306393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a single-isocenter technique for axillary radiotherapy in breast cancer.
    van Beek S; De Jaeger K; Mijnheer B; van Vliet-Vroegindeweij C
    Med Dosim; 2008; 33(3):191-8. PubMed ID: 18674683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
    Rusthoven KE; Raben D; Schneider C; Witt R; Sammons S; Raben A
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1365-70. PubMed ID: 19168295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
    Bollet MA; Sigal-Zafrani B; Mazeau V; Savignoni A; de la Rochefordière A; Vincent-Salomon A; Salmon R; Campana F; Kirova YM; Dendale R; Fourquet A
    Radiother Oncol; 2007 Mar; 82(3):272-80. PubMed ID: 17287037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Techniques of radiotherapy in so-called operable carcinoma of the breast].
    Pierquin B
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):429-35. PubMed ID: 17474652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.
    Freedman GM; Anderson P; Li T; Ross E; Swaby R; Goldstein L
    Cancer; 2006 Dec; 107(11):2552-8. PubMed ID: 17061250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment?
    Wang CW; Kuo WH; Chang KJ; Huang CS; Cheng JC
    J Surg Oncol; 2007 Aug; 96(2):144-50. PubMed ID: 17443743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.